Sorrento Therapeutics, Inc. Submits NDA For ZTlido Next-Generation Lidocaine Patch

SAN DIEGO, Aug. 29, 2017 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) ( " Sorrento " ), announced today that SCILEX Pharmaceuticals Inc. ( " SCILEX " ), a majority-owned subsidiary of Sorrento, resubmitted the NDA and responded to all of FDA...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news